Valuation: Olympus Corporation

Market Cap 2,206B 13.85B 12B 11.24B 10.26B 19.28B 1,321B 19.58B 132B 51.7B 662B 52.01B 50.88B P/E 2027 *
22.3x
P/E 2028 * 18.6x
Enterprise Value 2,288B 14.37B 12.45B 11.67B 10.64B 20B 1,371B 20.31B 137B 53.63B 686B 53.95B 52.78B EV / Sales 2027 *
2.14x
EV / Sales 2028 * 2.06x
Free-Float
94.53%
Yield 2027 *
1.49%
Yield 2028 * 1.55%
1 day-0.39%
1 week+10.44%
Current month+13.60%
1 month+16.45%
3 months+12.00%
6 months+11.61%
Current year+4.18%
1 week 1,843
Extreme 1843
2,128
1 month 1,703
Extreme 1703
2,128
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 31/05/2025
Director of Finance/CFO 59 31/03/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 31/03/2023
Director/Board Member 41 31/05/2019
Director/Board Member 63 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%+10.44%+16.25%+6.05% 13.85B
-0.33%+4.36%+26.31%+10.89% 223B
-0.80%+3.07%+0.03%-19.43% 145B
+0.01%+6.95%-16.09%+31.78% 142B
+0.45%+7.71%-49.90%+0.76% 74.52B
-0.65%+4.59%+20.95%+17.18% 53.63B
+0.51%-0.05%-15.92%-17.05% 50.14B
-0.84%+5.05%+26.36%+16.85% 41.87B
+0.28%+4.04%+45.75%+42.68% 40.89B
-0.65%+2.90%-2.86%+0.96% 32.65B
Average -0.24%+5.29%+5.09%+9.07% 81.69B
Weighted average by Cap. -0.26%+4.74%+4.04%+8.34%

Financials

2027 *2028 *
Net sales 1,071B 6.72B 5.83B 5.46B 4.98B 9.36B 641B 9.5B 64.2B 25.1B 321B 25.25B 24.7B 1,110B 6.97B 6.04B 5.66B 5.16B 9.71B 665B 9.86B 66.58B 26.03B 333B 26.18B 25.61B
Net income 100B 630M 546M 511M 467M 877M 60.1B 891M 6.02B 2.35B 30.09B 2.37B 2.31B 119B 750M 650M 609M 556M 1.04B 71.57B 1.06B 7.16B 2.8B 35.83B 2.82B 2.76B
Net Debt 82.51B 518M 449M 421M 384M 721M 49.42B 732M 4.95B 1.93B 24.74B 1.95B 1.9B 81.45B 512M 443M 415M 379M 712M 48.79B 723M 4.88B 1.91B 24.43B 1.92B 1.88B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
13/08/26 JP¥2,067.50 -0.39% 5,368,600
12/08/26 JP¥2,075.50 -1.10% 5,319,400
10/08/26 JP¥2,098.50 +10.10% 10,359,900
07/08/26 JP¥1,906.00 +1.82% 6,114,900
06/08/26 JP¥1,872.00 +3.60% 4,199,600
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,075.50JPY
Average target price
1,959.23JPY
Spread / Average Target
-5.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock